US Patent 11512132 Anti-PD-L1 antibodies and their use as therapeutics and diagnostics
Patent 11512132 was granted and assigned to BeiGene, Ltd on November, 2022 by the United States Patent and Trademark Office.
Currently, there are no issues on this topic.
Find more entities like US Patent 11512132 Anti-PD-L1 antibodies and their use as therapeutics and diagnostics
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
